GL1X · GenesisL1 explorer

Research workbench

Structure of human THR160-phospho CDK2-cyclin a complexed with a bisanilinopyrimidine inhibitor

Analyse Structure of human THR160-phospho CDK2-cyclin a complexed with a… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
2IW9
Type
protein
Length
1,073 residues
Chains
4
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Cell division protein kinase 2; Cyclin-A2
EC
2.7.1.37
UniProt
P24941, P20248
Ligands
4SP, MG
Pockets
12 · best druggability 0.81

Structure

x-ray diffraction · 4 distinct chains · 51% helix, 9% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ACell division protein kinase 2 (EC 2.7.1.37)protein29435% helix, 17% strandP24941
BCyclin-A2protein25568% helix, 0% strandP20248
CCell division protein kinase 2 (EC 2.7.1.37)protein26936% helix, 19% strandP24941
DCyclin-A2protein25567% helix, 0% strandP20248

Ligands and binding sites

  • 4SP · O6-cyclohexylmethoxy-2-(4'-sulphamoylanilino) purine · ligand · 2 copies · chains A, C
  • MG · Magnesium ion · metal · 2 copies · chains B, D
  • SGM · Monothioglycerol · additive · 2 copies · chains B, D

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

12 pockets found on a 1 Å grid, 10 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
11180.810.9923empty
21180.800.9823empty
311860.750.7897empty
42080.680.85224SP
52250.670.84264SP

Interfaces

5 interfaces between chains.

  • C–D · 1668 Ų buried · 22 hydrogen bonds · protein-protein
  • A–B · 1572 Ų buried · 23 hydrogen bonds · protein-protein
  • B–C · 553 Ų buried · 4 hydrogen bonds · protein-protein
  • A–D · 470 Ų buried · 3 hydrogen bonds · protein-protein
  • A–C · 109 Ų buried · 4 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 2 covalent, 2 modified (additive adduct, phosphorylation).

Compared structures

  • 2IW9 · Structure of human THR160-phospho CDK2-cyclin a complexed with a bisanilinopyrimidine… · the same entry in another collection · chain D against D, TM-score 1.00
  • P20248 · AlphaFold monomer V2.0 prediction for cyclin-A2 (P20248) · a predicted model of the same protein · chain D against A, TM-score 1.00
  • P24941 · AlphaFold monomer V2.0 prediction for cyclin-dependent kinase 2 (P24941) · a predicted model of the same protein · chain A against A, TM-score 0.92

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.